Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA: 603882)

Market Cap	12.89B
Revenue (ttm)	8.25B
Net Income (ttm)	448.19M
Shares Out	464.79M
EPS (ttm)	0.96
PE Ratio	29.01
Forward PE	21.10
Dividend	0.88 (3.17%)
Ex-Dividend Date	Jun 18, 2024

Volume	4,153,762
Open	28.27
Previous Close	28.21
Day's Range	27.61 - 28.35
52-Week Range	24.61 - 69.60
Beta	0.55
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Guangzhou Kingmed Diagnostics Group

Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. The company also offers clinical research, health management, cold chain logistics, and scientific research services, as well as vitro diagnostics, big data, artificial intelligence, and forensic testing services. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2006
• Employees: 11,586
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603882

Financial Performance

In 2023, 603882's revenue was 8.54 billion, a decrease of -44.82% compared to the previous year's 15.48 billion. Earnings were 643.38 million, a decrease of -76.64%.